Pharmacogenomics
We read your genes before we prescribe.
For most of medicine's history, we've learned your biology the hard way: give a medication, and find out from the side effects how your body handles it. There is a better way, and it's finally here.
The instruction booklet
Decades ago, when the first disease genes were mapped, the promise was that we'd soon have the instruction booklet for the human body, and prescribe accordingly. That future arrived in the lab a long time ago. It mostly hasn't reached the exam room. Even excellent doctors still prescribe common medications without ever checking whether your genes can tolerate them.
Your DNA largely determines how you metabolize medications. The same dose that helps one person can do nothing for another and harm a third. A simple genetic readout can tell which is which, in advance.
How we do it
- We bring your genetic data into your chart, whether from a consumer test you already have or clinical-grade sequencing we arrange.
- Our clinical intelligence screens it against established prescribing guidelines for the genes that matter most.
- Before any prescription, it flags a conflict (a drug to avoid, a dose to adjust, or a safer alternative) with the evidence behind it.
- Your physician reviews the flag and makes the call. The system advises; it never overrides your doctor.
Screening, then confirmation
A consumer genetic test is a powerful starting point, enough to raise a flag. When a result would change a real prescribing decision, we confirm it with clinical-grade testing before acting. You get the speed of screening now and the certainty of confirmation when it counts.
Why it matters
This is personal for our founder, who carries a gene for severe reactions to a very common class of medication, and was once prescribed exactly that, without anyone checking first. The goal of One Tree Medical is simple: find the landmines before you step on them, not after.
Genes are only one signal. We pair this with cost transparency and your own portable record.